Berkeley Lights
  • Platform
    • Workflows
      • Antibody Discovery
        • Viral Neutralization
      • Cell Line Development
      • Cell Therapy Development
      • Synthetic Biology
    • Advanced Automation
      • The Beacon® Optofluidic System
      • The Lightning™ Optofluidic System
      • The Culture Station™ System
  • Technology
  • Company
    • News
    • Press Releases
    • Customer Spotlights
    • Blog
    • BLI News
    • Events
    • Investors
    • Careers
  • Resources
  • Support
  • Get In Touch
Latest

Blog

Blog 03.02.21

Ask Me Anything: A world of change

Blog 02.23.21

Racing to find the right cells: Our COVID-19 success stories

Blog 02.19.21

Cell Therapy Development and Improving Patient Access

Blog 11.27.20

AstraZeneca enters Phase III clinical trials using antibodies found on the Berkeley Lights Beacon® system

Blog 06.25.20

Collision from Home Panel Recap: Berkeley Lights CEO Dr. Eric Hobbs Talks COVID-19 Antibody Discovery

Blog 04.20.20

Speeding the COVID-19 Drug Development Process

Blog 04.13.20

COVID-19 Fact or Fiction

Blog 04.01.20

Everything You Need to Know About Coronavirus

Blog 03.25.20

Shortening Long Drug and Vaccine Development Timelines: Beating Coronavirus with Antibody Discovery

  • Platform
  • Company
  • Careers
  • Resources
  • Support
  • Get In Touch

General Inquiries

info@berkeleylights.com
+1 (510) 858-2855

Tech Support

techsupport@berkeleylights.com
+1 (888) 254-5595 / Ext. 4

Subscribe to our quarterly newsletter, BLI News.

Check out our current issue

© 2021 Berkeley Lights. All Rights Reserved. Site by Metropolis.

  • Privacy Policy
  • Terms of Use
  • Patents